NCT02447601View on ClinicalTrials.gov

Evaluate the Pharmacokinetics of Simvastatin When Coadministered With PEX168 in Healthy Adult Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

March 30, 2015

Primary Completion Date

May 14, 2015

Study Completion Date

August 11, 2015

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

PEX168

200µg,injected subcutaneously,once a week.

DRUG

Simvastatin

40mg,oral,two times

Trial Locations (1)

200122

Shanghai Mental Health Center (SMHC), Shanghai

Sponsors
All Listed Sponsors
lead

Jiangsu Hansoh Pharmaceutical Co., Ltd.

INDUSTRY